Compare Cassava Sciences Inc (FLNA) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs J B Hunt Transport Services Inc — how do they compare? Cassava Sciences Inc trades at $1.1 (market cap $53.14M), while J B Hunt Transport Services Inc trades at $298.41 (market cap $26.04B). The key difference: J B Hunt Transport Services Inc is far larger — about 490× Cassava Sciences Inc's market cap, and J B Hunt Transport Services Inc pays a 0.65% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | JBHT | |
|---|---|---|
Market Cap | $53.14M | $26.04B |
Sector | Health | Industrials |
52-Week High | $4.64 | $290.07 |
52-Week Low | $1.09 | $130.65 |
Enterprise Value | -$33.43M | $27.18B |
Dividend Yield | — | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
JBHT stock trades at $296.43, up 5.54% following strong Q2 2026 earnings that beat expectations with $1.91 EPS on $3.5 billion revenue. The stock shows bullish technical momentum with consistent earnings beats over the last four quarters and analyst consensus favoring buy ratings. Recent performance reflects improved freight market conditions and operational efficiency gains.
Outlook remains positive with structural industry shifts supporting growth, though valuation multiples appear elevated. Key risks include freight market cyclicality and competitive pressures. Analyst price targets suggest moderate upside potential from current levels with consensus at $289.38.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
